Viz.ai

Viz helps to establish quick communication between frontline medical professionals and multidisciplinary specialists. Communication is compliant with security standards.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
  • Combo news

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
$  Share Price
Growth Capital22 Mar 2023
***
***
$...
Series D 7 Apr 2022
***
***
$...
Series C17 Mar 2021
***
***
$...
Series B23 Oct 2019
***
***
$...
Series A18 Jul 2018
***
***
$...
Seed24 May 2017
***
***
$...
Seed 5 Oct 2016
***
***
$...

*** - To view the data, please log into your account or create a new one.

Investors

Tiger Global ManagementTiger Global Management
Insight PartnersInsight Partners
Kleiner PerkinsKleiner Perkins
GVGV
CRVCRV
Scale Venture PartnersScale Venture Partners
Greenoaks CapitalGreenoaks Capital
Innovation EndeavorsInnovation Endeavors
DHVCDHVC
More (1)

News related to Viz.ai

Viz.aiViz.ai • 24 May 2023

Viz.ai at TVT 2023

Join Viz.ai at TVT to discuss the challenges of cardiac care and the latest in AI innovation to streamline clinical care....

Viz.ai
https://www.viz.ai/events/tvt-2023
Viz.aiViz.ai • 16 May 2023

Viz.ai at AiMed Global Summit 2023

Visit with Viz.ai at AIMED this year to learn more about how Viz.ai can help to streamline workflow to save clinicians time and expedite care for patients....

Viz.ai
https://www.viz.ai/events/aimed-global-summit-2023
Viz.aiViz.ai •  4 May 2023

Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory ...

Leading experts to shape the future of Viz.ai's HCM strategy and platform. SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leader in AI-powered disease ...

https://www.streetinsider.com/Business+Wire/Viz.ai+Appoints+Hypertrophic+Cardiomyopathy+Medical+Advisory+Board+to+Advance+Innovation/21610089.html
More (25)

Viz.ai Twitter